Telomir Pharmaceuticals, Inc. Common Stock
TELONASDAQHealthcareBiotechnology
Latest quote
$1.185
Market data unavailable
Aug 24, 10:53 AM ET
TELO company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
32/100
GoAI score
Sell
Trim exposure — unfavorable risk-reward
Valuation
28
Expensive
Momentum
34
Weakening
Sentiment
53
Mixed
Risk resilience
34
High Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
- Industry
- Biotechnology
- Sector
- Healthcare
- Headquarters
- US
Market position
- Volume
- 2.43K
- Market cap
- 79.44M USD
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 35.29M USD
- EV / EBITDA
- -3.39×
- Earnings yield
- -24.74%
- Free cash flow yield
- -8.76%
Profitability & efficiency
- Return on equity
- -176.10%
- Return on assets
- -141.84%
- Return on invested capital
- -165.00%
Financial health
- Current ratio
- 5.14×
Earnings
- EPS beat rate
- 50%
- 4 beats, 4 misses, 0 met estimates
- Average EPS surprise
- -172.81%
- 8 comparable reports
- Latest EPS result
- -0.79
- Estimate -0.07 · Miss by 1028.57%
EPS: actual versus estimate
Recent quarterly results
ActualEstimate
Revenue: actual versus estimate
Recent quarterly results
ActualEstimate
TELO news
TELO peers
ETFs holding TELO
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 1.36M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $377.17-0.28%
Vanguard Extended Market ETFVXF- Market value
- 571.87K
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $243.77-0.72%
iShares Micro-Cap ETFIWC- Market value
- 42.56K
- Weight
- 0.00%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $197.74-0.20%
Continue in GoAI
Research TELOresearch.disclaimer